(Q43749300)

26 November 2017

1 reference

title

Prevention of osteoporotic fractures--should orthopedic surgeons care? (English)

1 reference

26 November 2017

0 references

Obrant KJ

1

1 reference

26 November 2017

publication date

1 August 1998

1 reference

26 November 2017

1 reference

26 November 2017

volume

69

1 reference

26 November 2017

issue

4

1 reference

26 November 2017

page(s)

333-338

1 reference

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F17453679808999041

Vitamin D3 and calcium to prevent hip fractures in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17453679808999041

Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17453679808999041

Hip fractures in the elderly: a world-wide projection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17453679808999041

Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17453679808999041

Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17453679808999041

Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17453679808999041

Prevention of fractures in the elderly. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17453679808999041

A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17453679808999041

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17453679808999041

Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17453679808999041

The effects of calcium supplementation (milk powder or tablets) and exercise on bone density in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17453679808999041

Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17453679808999041

The scientific basis of recommended dietary allowances for calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17453679808999041

Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: a retrospective and prospective population-based study of women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17453679808999041

The incidence of hip fractures in independent and institutionalized elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17453679808999041

A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17453679808999041

10.3109/17453679808999041

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference